AbbVie Joins US Drug Rebate Pilot
AbbVie will participate in a US government pilot starting next year to test a new rebate system for discounted medicines under the 340B program. The initiative aims to improve pricing transparency and prevent duplicate discounts for key drugs.
Xurve View
Insights:
Xurve View
ABBVIE INC will join a United States government pilot program to test a new drug discount rebate system starting January 1, 2027. The initiative tests pricing models under the 340B program for low-income healthcare providers. The rollout helps prevent duplicate discounts as Medicare-negotiated drug prices take effect.
